Related Experiment Video

Updated: May 15, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Kinase drug discovery--what's next in the field?

Philip Cohen1, Dario R Alessi

  • 1MRC Protein Phosphorylation Unit, University of Dundee, Dundee DD1 5EH, United Kingdom. p.cohen@dundee.ac.uk

ACS Chemical Biology
|January 2, 2013
PubMed

Insights

Protein kinases are crucial drug targets for cancer and inflammation. New research explores targeting the MyD88 pathway for autoimmune diseases and highlights pseudo-kinases as promising drug targets.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Protein kinases are a major focus for drug development, particularly in oncology.
  • Recent approvals for inflammatory diseases and advances in immunology signal growing interest in kinase inhibitors for immune-related conditions.

Purpose of the Study:

  • To explore targeting the MyD88 signaling network for treating chronic inflammatory and autoimmune diseases.
  • To discuss the potential of SPAK/OSR1 and LRRK2 kinases as therapeutic targets for hypertension and Parkinson's disease, respectively.
  • To highlight pseudo-kinases as a novel and underexplored area for drug discovery.

Main Methods:

  • Review of current literature on protein kinase inhibitors and signaling pathways.
  • Analysis of MyD88 signaling network in the context of inflammation and autoimmune diseases.
  • Discussion of drug development strategies, including targeting kinase activation and pseudo-kinases.

Main Results:

  • Protein kinase inhibitors are increasingly important in treating cancer and inflammatory diseases.
  • The MyD88 signaling network presents opportunities for novel anti-inflammatory and autoimmune drug development.
  • SPAK/OSR1 and LRRK2 kinases are identified as promising targets for hypertension and Parkinson's disease.

Conclusions:

  • Targeting protein kinases offers significant therapeutic potential beyond cancer, particularly in inflammatory and autoimmune diseases.
  • Developing inhibitors that target kinase activation and exploring pseudo-kinases could lead to more specific and effective treatments for various diseases.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...